Fundraising FoxMolten Ventures — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
IMU Biosciences builds an immune-system analysis platform that measures over 100 million datapoints from a single blood sample across large patient populations, an approach it calls HD Immunology.
AI & Machine LearningBiotechHealthtechLondon, GB
Thomas Hayday PhD(Co-founder & Chief Research Officer)Adam Laing PhD(Co-founder & Chief Scientific Officer)Mario Cantero MBA(Co-founder & Chief Operating Officer)Adam Laing(Founder)inJohn Baker PhD(Chief Executive Officer)
Co-investorsExpaIQ CapitalKfundLifeX Ventures
.jpeg){kind=logo}
Manna operates an air delivery service using drone technology to deliver medical equipment, food, and other goods, with plans to reduce traffic and improve air quality in urban areas.
Deep TechLogistics & Supply ChainMobility & TransportationTulsa, IE
Bobby Healy(Founder)in
Co-investorsAtlantic Bridge VenturesFf Venture CapitalFrontline VenturesGaingelsRadius Capital VenturesSchooner Capital+7 more
__Twitter.png)
Modo builds software that guides employees inside their existing workflows to select and use the right AI tools for specific tasks, while giving leadership data on adoption and results.
AI & Machine LearningEnterprise SoftwareFuture of WorkSaaS
Johnny Chang(Co-Founder)inAngelina You(Co-Founder)in
Co-investorsJFFLabs, INC.One Way VenturesETF Partners
Qureight is a UK AI-powered imaging CRO providing enterprise-grade imaging and precision endpoints for lung and heart disease trials.
Cambridge, GB
Muhunthan Thillai(Chief Executive Officer & Co-founder)in
Co-investorsAscensionCambridge Angels groupGuinness VenturesCMS VenturesPlayfair CapitalXTX Markets
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.